Cargando…

Opposite Cannabis-Cognition Associations in Psychotic Patients Depending on Family History

The objective of this study is to investigate cognitive performance in a first-episode psychosis sample, when stratifying the interaction by cannabis use and familial or non-familial psychosis. Hierarchical-regression models were used to analyse this association in a sample of 268 first-episode psyc...

Descripción completa

Detalles Bibliográficos
Autores principales:	González-Pinto, Ana, González-Ortega, Itxaso, Alberich, Susana, Ruiz de Azúa, Sonia, Bernardo, Miguel, Bioque, Miquel, Cabrera, Bibiana, Corripio, Iluminada, Arango, Celso, Lobo, Antonio, Sánchez-Torres, Ana M., Cuesta, Manuel J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981356/ https://www.ncbi.nlm.nih.gov/pubmed/27513670 http://dx.doi.org/10.1371/journal.pone.0160949

Ejemplares similares

S229. THE EFFECT OF FAMILY ENVIRONMENT ON LONGITUDINAL FUNCTIONING IN FIRST PSYCHOTIC EPISODES
por: Verdolini, Norma, et al.
Publicado: (2020)

F245. COGNITIVE RESERVE DIFFERENCE IN AFFECTIVE AND NONAFFECTIVE PSYCHOSIS
por: Amoretti, Silvia, et al.
Publicado: (2018)

Prognostic Value of Affective Symptoms in First-Admission Psychotic Patients
por: Arrasate, Marta, et al.
Publicado: (2016)

Cognitive Behavioral Therapy Program for Cannabis Use Cessation in First-Episode Psychosis Patients: A 1-Year Randomized Controlled Trial
por: González-Ortega, Itxaso, et al.
Publicado: (2022)

A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project
por: Bioque, Miquel, et al.
Publicado: (2015)

Subclinical Depressive Symptoms and Continued Cannabis Use: Predictors of Negative Outcomes in First Episode Psychosis
por: González-Ortega, Itxaso, et al.
Publicado: (2015)

The effect of early life events on glucose levels in first-episode psychosis
por: Garcia-Rizo, Clemente, et al.
Publicado: (2022)

Cannabis and First-Episode Psychosis: Different Long-term Outcomes Depending on Continued or Discontinued Use
por: González-Pinto, Ana, et al.
Publicado: (2011)

Psychometric properties and validation of a four-item version of the Strauss–Carpenter scale in bipolar disorder
por: Alberich, Susana, et al.
Publicado: (2016)

Link between cognitive polygenic risk scores and clinical progression after a first-psychotic episode
por: Segura, Alex G., et al.
Publicado: (2023)

The search for new biomarkers for cognition in schizophrenia
por: Penadés, Rafael, et al.
Publicado: (2015)

Cannabis use and involuntary admission may mediate long-term adherence in first-episode psychosis patients: a prospective longitudinal study
por: Barbeito, Sara, et al.
Publicado: (2013)

Gene co-expression architecture in peripheral blood in a cohort of remitted first-episode schizophrenia patients
por: Rodríguez, Natalia, et al.
Publicado: (2022)

F12. INFLAMMATORY BIOMARKERS AND COGNITION IN FIRST EPISODE PSYCHOSIS: GENDER DIFFERENCES
por: Llorca, Bibiana Cabrera, et al.
Publicado: (2018)

Cognitive behavioral therapy program for cannabis use cessation in first-episode psychosis patients: study protocol for a randomized controlled trial
por: González-Ortega, Itxaso, et al.
Publicado: (2016)

The Role of Premorbid IQ and Age of Onset as Useful Predictors of Clinical, Functional Outcomes, and Recovery of Individuals with a First Episode of Psychosis
por: Molina-García, Mariola, et al.
Publicado: (2021)

Social cognition as a mediator between cognitive reserve and psychosocial functioning in patients with first episode psychosis
por: González-Ortega, I., et al.
Publicado: (2021)

Psychotic Cannabis Withdrawal: A Clinical Case
por: Ramos, Berta, et al.
Publicado: (2022)

Exploring Risk and Resilient Profiles for Functional Impairment and Baseline Predictors in a 2-Year Follow-Up First-Episode Psychosis Cohort Using Latent Class Growth Analysis
por: Salagre, Estela, et al.
Publicado: (2020)

Cognitive impairment in first psychotic episodes: The role of cannabis
por: Boi, S., et al.
Publicado: (2021)

Cognition in Recent Suicide Attempts: Altered Executive Function
por: Fernández-Sevillano, Jessica, et al.
Publicado: (2021)

Women Undergoing Hormonal Treatments for Infertility: A Systematic Review on Psychopathology and Newly Diagnosed Mood and Psychotic Disorders
por: González-Rodríguez, Alexandre, et al.
Publicado: (2020)

Clozapine and paliperidone palmitate antipsychotic combination in treatment-resistant schizophrenia and other psychotic disorders: A retrospective 6-month mirror-image study
por: Bioque, Miquel, et al.
Publicado: (2020)

Opposition to cannabis legalization on public health grounds
por: Smyth, Bobby P, et al.
Publicado: (2021)

Online psycho-education to the treatment of bipolar disorder: protocol of a randomized controlled trial
por: González-Ortega, Itxaso, et al.
Publicado: (2016)

Cardiovascular Risk in Early Psychosis: Relationship with Inflammation and Clinical Features 6 Months after Diagnosis
por: Barcones, Maria Fe, et al.
Publicado: (2017)

Profile of paliperidone palmitate once-monthly long-acting injectable in the management of schizophrenia: long-term safety, efficacy, and patient acceptability – a review
por: González-Rodríguez, Alexandre, et al.
Publicado: (2015)

Salience attribution and its relationship to cannabis-induced psychotic symptoms
por: Bloomfield, M. A. P., et al.
Publicado: (2016)

Attenuated Psychotic Symptoms in Adolescents With Chronic Cannabis and MDMA Use
por: Wiedmann, Melina, et al.
Publicado: (2022)

A Multicentre, Randomised, Controlled Trial of a Combined Clinical Treatment for First-Episode Psychosis
por: González-Ortega, Itxaso, et al.
Publicado: (2021)

The opposite effects of fluvoxamine and sertraline in the treatment of psychotic major depression: a case report
por: Kishimoto, Akira, et al.
Publicado: (2010)

Rates and correlates of cannabis-associated psychotic symptoms in over 230,000 people who use cannabis
por: Schoeler, Tabea, et al.
Publicado: (2022)

The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study
por: Di Forti, Marta, et al.
Publicado: (2019)

The Influence of Oxytocin and Prolactin During a First Episode of Psychosis: The Implication of Sex Differences, Clinical Features, and Cognitive Performance
por: Hidalgo-Figueroa, María, et al.
Publicado: (2022)

Association of Prolactin, Oxytocin, and Homocysteine With the Clinical and Cognitive Features of a First Episode of Psychosis Over a 1-Year Follow-Up
por: Hidalgo-Figueroa, Maria, et al.
Publicado: (2023)

Adversity, cannabis use and psychotic experiences: evidence of cumulative and synergistic effects
por: Morgan, Craig, et al.
Publicado: (2014)

Association of Combined Patterns of Tobacco and Cannabis Use in Adolescence With Psychotic Experiences
por: Jones, Hannah J., et al.
Publicado: (2018)

The effect of COVID-19 pandemic on admissions for cannabis-induced psychotic disorder
por: Elias De Sousa, A., et al.
Publicado: (2022)

Avatar Intervention for cannabis use disorder in patients with psychotic and mood disorders
por: Giguère, S., et al.
Publicado: (2023)

Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders
por: Sami, Musa Basseer, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jm51q9su24tba0dfvujk8bdpae